Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) — Strategic Asset Allocation Index
Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Strategic Asset Allocation Index of 65.3% as of June 2023. Strategic assets (PP&E of CN¥2.44 Billion plus long-term investments of CN¥-) total CN¥2.44 Billion, measured against net assets of CN¥3.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of Shandong Jincheng Pharmaceutical and Che to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Strategic Asset Allocation Index (2008–2021)
This chart shows how Shandong Jincheng Pharmaceutical and Chemical Co Ltd's Strategic Asset Allocation Index has evolved across 14 annual periods from 2008 to 2021. As of June 2023, the index stands at 65.3%, representing strategic assets of CN¥2.44 Billion against net assets of CN¥3.73 Billion CNY. See 300233 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2021, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Shandong Jincheng Pharmaceutical and Che (300233) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 60.8% | CN¥2.09 Billion | CN¥2.09 Billion | CN¥- | CN¥3.44 Billion | ▲ +9.6 pp |
| 2020 | 51.3% | CN¥1.78 Billion | CN¥1.78 Billion | CN¥- | CN¥3.47 Billion | ▲ +9.6 pp |
| 2019 | 41.7% | CN¥1.70 Billion | CN¥1.70 Billion | CN¥- | CN¥4.08 Billion | ▲ +2.2 pp |
| 2018 | 39.5% | CN¥1.61 Billion | CN¥1.50 Billion | CN¥117.33 Million | CN¥4.09 Billion | ▲ +4.3 pp |
| 2017 | 35.2% | CN¥1.39 Billion | CN¥1.33 Billion | CN¥60.96 Million | CN¥3.94 Billion | ▼ -24.7 pp |
| 2016 | 59.9% | CN¥900.61 Million | CN¥843.31 Million | CN¥57.30 Million | CN¥1.50 Billion | ▲ +0.2 pp |
| 2015 | 59.7% | CN¥781.91 Million | CN¥774.61 Million | CN¥7.30 Million | CN¥1.31 Billion | ▼ -8.9 pp |
| 2014 | 68.6% | CN¥766.02 Million | CN¥766.02 Million | CN¥- | CN¥1.12 Billion | ▼ -3.4 pp |
| 2013 | 72.0% | CN¥735.76 Million | CN¥735.76 Million | CN¥- | CN¥1.02 Billion | ▲ +10.4 pp |
| 2012 | 61.6% | CN¥600.89 Million | CN¥600.89 Million | CN¥- | CN¥975.57 Million | ▲ +4.0 pp |
| 2011 | 57.6% | CN¥552.04 Million | CN¥552.04 Million | CN¥- | CN¥958.84 Million | ▼ -64.9 pp |
| 2010 | 122.5% | CN¥459.85 Million | CN¥459.85 Million | CN¥- | CN¥375.33 Million | ▲ +6.2 pp |
| 2009 | 116.3% | CN¥327.50 Million | CN¥327.50 Million | CN¥- | CN¥281.53 Million | ▲ +26.5 pp |
| 2008 | 89.8% | CN¥194.41 Million | CN¥194.41 Million | CN¥- | CN¥216.49 Million | — |